Managing Your Intraocular Pressure (IOP)
Because elevated IOP has no or few symptoms, even when you're taking LUMIGAN®
regularly, it's important to get checkups with your eye doctor on a regular basis.
Your eye doctor may use several of the following tests to determine the advancement
of your glaucoma:
- Applanation tonometry: After you're given eye-numbing drops, your
doctor uses special equipment to touch your cornea and take an IOP measurement.
- Air puff tonometry: A painless puff of air is blown toward your
eye in order to take an IOP measurement.
- Dilated eye exam: After your pupils are dilated (widened) with
special drops, the doctor uses an ophthalmoscope to view the back of the eye to
check for any changes in the optic nerve.
- Perimetry test: You're exposed to a series of light flashes on
a screen, and you press a button when you see one. This test is considered to be
the best in determining disease progression and/or visual field defect for patients
with glaucoma.
See your eye doctor regularly and find out as much as you can about preserving your
eyesight.
LUMIGAN® 0.01% and 0.03% (bimatoprost ophthalmic solution) is used
for the treatment of high eye pressure, also called intraocular pressure (IOP),
in people with open-angle glaucoma or ocular hypertension.
Important Safety Information
LUMIGAN® 0.01% and 0.03% (bimatoprost ophthalmic solution) has been
reported to cause darkening (pigmentation) of eye color, eyelid skin, and eyelashes
as well as increased growth of eyelashes. Pigmentation changes can increase as long
as LUMIGAN® 0.01% and 0.03% is used. After stopping LUMIGAN®
0.01% and 0.03%, darkening of eye color is likely to be permanent, while darkening
of the eyelid skin and eyelash changes may be reversible. The effects of increased
darkening beyond 5 years are not known.
When only one eye is treated, there is a possibility of eyelash changes in the eye
treated with LUMIGAN® 0.01% and 0.03%. These changes may result in
differences between the eyes in eyelash length, thickness, darkness, number of eyelashes,
and/or direction of eyelash growth. These changes are usually reversible upon stopping
LUMIGAN® 0.01% and 0.03% therapy.
Avoid allowing the tip of the dispensing bottle to touch the eye, anything around
the eye, fingers, or any other surface in order to avoid contamination by common
bacteria known to cause eye infections. Serious damage to the eye and loss of vision
may result from using contaminated solutions.
If you have eye surgery or develop any eye reactions (such as trauma or infection),
immediately consult with your physician about continuing the use of LUMIGAN®
0.01% and 0.03%.
If you wear contact lenses, remove them before using LUMIGAN® 0.01%
and 0.03%. Then wait 15 minutes after using LUMIGAN® 0.01% and 0.03%
before you put your contacts back into your eyes.
The most common side effects are eye redness, growth of eyelashes, and itchy eyes.
Click here
for full prescribing information.